Clinical Trial Update: RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDS [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the combination of everolimus (RAD001) with midostaurin (PKC412) in relapsed, refractory, or poor-prognosis acute myelo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Everolimus (everolimus)
• Midostaurin (midostaurin)

Snippet

Sponsor: Richard Stone, MD | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 1 | Status: ACTIVE_NOT_RECRUITING